Exact Sciences raises 2025 revenue guidance to $3.235B amid Cologuard Plus expansion and Cancerguard launch (NASDAQ:EXAS)

Group 1 - The article discusses the importance of enabling Javascript and cookies in browsers to prevent access issues [1] - It highlights that users with ad-blockers may face restrictions when trying to access content [1]